News Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXAยฎ (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:…Super UserMay 16, 2022
News Emmes Supports Landmark mRNA COVID-19 Vaccine Trial in Sub-Saharan Africa ROCKVILLE, Md., May 16, 2022 /PRNewswire/ -- Emmes, a global, full-service clinical…Super UserMay 16, 2022
News Sponsored Deloitte: Why now could be a great time to start preparing for an IPO | Crain’s New York Business No question about itโ2021 was a banner year for initial public offerings.…Super UserMay 16, 2022
News The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs – Drug Discovery & Development MIMETAS, a global leader in Organ-on-a-Chip models and technology and headquartered in…Super UserMay 16, 2022
News IndyGeneUS AI Awarded Grant Funding through QuickFire Challenge IndyGeneUS plans to use the grant funding from Johnson & Johnson Innovation…Super UserMay 13, 2022
News Another Federal Regional Cluster Funding Opportunity Emerges By: Brian Darmody, Chief Strategy Officer, AURP: Building Communities of Innovation May…Super UserMay 12, 2022
News QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A. | Business Wire HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard:…Super UserMay 12, 2022
News Qiagen N.V. – QIAGEN acquires majority stake in enzymes provider BLIRT S.A. HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime…Super UserMay 12, 2022
News Cartesian Therapeutics to Present Late-Breaking Data from Phase 1/2a Trial of RNA CAR T-cell Therapy in Patients with Generalized Myasthenia Gravis - Data Presentation Today at 14th Myasthenia Gravis Foundation of America International…Super UserMay 12, 2022
News Emmes launches Advantage eClinical as a standalone cloud native clinical technology platform The cloud platform will empower biotech companies and CROs with an integrated…Super UserMay 12, 2022